MAGEA3 and colorectal carcinoma: Nevertheless, our study shows that there are some CTAs expressed at higher frequencies (p < 0.05) in CRC patient samples (MAGEA3, OIP5, TTK, PLU1, DKKL1, and FBXO39, Table 2).